These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 36450103)

  • 1. Multiomics of Colorectal Cancer Organoids Reveals Putative Mediators of Cancer Progression Resulting from SMAD4 Inactivation.
    Dijkstra JJ; Neikes HK; Rezaeifard S; Ma X; Voest EE; Tauriello DVF; Vermeulen M
    J Proteome Res; 2023 Jan; 22(1):138-151. PubMed ID: 36450103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimetastatic role of Smad4 signaling in colorectal cancer.
    Zhang B; Halder SK; Kashikar ND; Cho YJ; Datta A; Gorden DL; Datta PK
    Gastroenterology; 2010 Mar; 138(3):969-80.e1-3. PubMed ID: 19909744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the ERK pathway reduces liver metastasis of Smad4-inactivated colorectal cancer.
    Ai X; Wu Y; Zhang W; Zhang Z; Jin G; Zhao J; Yu J; Lin Y; Zhang W; Liang H; Datta PK; Zhang M; Zhang B; Chen X
    Cancer Biol Ther; 2013 Nov; 14(11):1059-67. PubMed ID: 24025354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Black Raspberries Suppress Colorectal Cancer by Enhancing Smad4 Expression in Colonic Epithelium and Natural Killer Cells.
    Huang YW; Lin CW; Pan P; Shan T; Echeveste CE; Mo YY; Wang HT; Aldakkak M; Tsai S; Oshima K; Yearsley M; Xiao J; Cao H; Sun C; Du M; Bai W; Yu J; Wang LS
    Front Immunol; 2020; 11():570683. PubMed ID: 33424832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
    Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
    Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad4 inactivation promotes malignancy and drug resistance of colon cancer.
    Papageorgis P; Cheng K; Ozturk S; Gong Y; Lambert AW; Abdolmaleky HM; Zhou JR; Thiagalingam S
    Cancer Res; 2011 Feb; 71(3):998-1008. PubMed ID: 21245094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin.
    Freeman TJ; Smith JJ; Chen X; Washington MK; Roland JT; Means AL; Eschrich SA; Yeatman TJ; Deane NG; Beauchamp RD
    Gastroenterology; 2012 Mar; 142(3):562-571.e2. PubMed ID: 22115830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway.
    Zhang B; Zhang B; Chen X; Bae S; Singh K; Washington MK; Datta PK
    Br J Cancer; 2014 Feb; 110(4):946-57. PubMed ID: 24384683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of SMAD4 alters BMP signaling to promote colorectal cancer cell metastasis via activation of Rho and ROCK.
    Voorneveld PW; Kodach LL; Jacobs RJ; Liv N; Zonnevylle AC; Hoogenboom JP; Biemond I; Verspaget HW; Hommes DW; de Rooij K; van Noesel CJ; Morreau H; van Wezel T; Offerhaus GJ; van den Brink GR; Peppelenbosch MP; Ten Dijke P; Hardwick JC
    Gastroenterology; 2014 Jul; 147(1):196-208.e13. PubMed ID: 24704720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the molecular mechanisms and therapeutic potential of SMAD4 in colorectal cancer.
    Shan H; Tian G; Zhang Y; Qiu Z
    Cancer Biol Ther; 2024 Dec; 25(1):2392341. PubMed ID: 39164192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4.
    Cheng D; Zhao S; Tang H; Zhang D; Sun H; Yu F; Jiang W; Yue B; Wang J; Zhang M; Yu Y; Liu X; Sun X; Zhou Z; Qin X; Zhang X; Yan D; Wen Y; Peng Z
    Oncotarget; 2016 Jul; 7(29):45199-45213. PubMed ID: 27286257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMAD7 and SMAD4 expression in colorectal cancer progression and therapy response.
    Rosic J; Dragicevic S; Miladinov M; Despotovic J; Bogdanovic A; Krivokapic Z; Nikolic A
    Exp Mol Pathol; 2021 Dec; 123():104714. PubMed ID: 34717960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy-specific glycoprotein 9 (PSG9), a driver for colorectal cancer, enhances angiogenesis via activation of SMAD4.
    Yang L; Hu S; Tan J; Zhang X; Yuan W; Wang Q; Xu L; Liu J; Liu Z; Jia Y; Huang X
    Oncotarget; 2016 Sep; 7(38):61562-61574. PubMed ID: 27528036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMAD4 Loss Induces c-MYC-Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis.
    Loevenich LP; Tschurtschenthaler M; Rokavec M; Silva MG; Jesinghaus M; Kirchner T; Klauschen F; Saur D; Neumann J; Hermeking H; Jung P
    Cancer Res; 2022 Dec; 82(24):4604-4623. PubMed ID: 36219392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of transforming growth factor beta (TGF-β) signaling axis molecules and E-cadherin in colorectal cancer.
    Lampropoulos P; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
    Tumour Biol; 2012 Aug; 33(4):1005-14. PubMed ID: 22278155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIF1γ and SMAD4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis.
    Wu Y; Yu B; Ai X; Zhang W; Chen W; Laurence A; Zhang M; Chen Q; Shao Y; Zhang B
    Biol Chem; 2024 Apr; 405(4):241-256. PubMed ID: 38270141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hedyotis diffusa Willd suppresses metastasis in 5‑fluorouracil‑resistant colorectal cancer cells by regulating the TGF‑β signaling pathway.
    Lai Z; Yan Z; Chen W; Peng J; Feng J; Li Q; Jin Y; Lin J
    Mol Med Rep; 2017 Nov; 16(5):7752-7758. PubMed ID: 28944846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
    Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
    Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of somatic SMAD4 mutations in colorectal liver metastases.
    Xourafas D; Mizuno T; Cloyd JM
    Chin Clin Oncol; 2019 Oct; 8(5):52. PubMed ID: 31500428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smad4 acts as tumor suppressor by antagonizing lymphangiogenesis in colorectal cancer.
    Liu Y; Sheng J; Dai D; Liu T; Qi F
    Pathol Res Pract; 2015 Apr; 211(4):286-92. PubMed ID: 25680269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.